About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

B-279238 1 (1998-05-21)

handle is hein.gao/gaocrptahry0001 and id is 1 raw text is: 


oComptroller General
             of the United States
             Washington, D.C. 20548
             Decision




             Matter of: Boehringer Mannheim Corporation

             File:       B-279238

             Date:       May 21, 1998

             Robert M. Jenkins III, Esq., Harkins Cunningham, for the protester.
             Timothy Sullivan, Esq., and Katherine S. Nucci, Esq., Adduci, Mastriani &
             Schaumberg, for Abbott Laboratories, an intervenor.
             Phillipa L. Anderson, Esq., and Melbourne A. Noel, Jr., Esq., Department of Veterans
             Affairs, for the agency.
             Win. David Hasfurther, Esq., and Michael R. Golden, Esq., Office of the General
             Counsel, GAO, participated in the preparation of the decision.
             DIGEST

             Blanket purchase agreement (BPA) with vendor for blood glucose monitoring
             products, which was executed pursuant to Federal Acquisition Regulation (FAR)
             Subpart 8.4, is not legally objectionable notwithstanding the inclusion in the BPA of
             a conditional discount for other products sold by that vendor under another BPA.
             DECISION

             Boehringer Mannheim Corporation (BMC) protests the terms of a blanket purchase
             agreement (BPA) entered into by the Abbott Diagnostics Division and Veterans
             Integrated Service Network No. 7 (VISN 7), Department of Veterans Affairs (VA),
             for blood glucose monitoring products. BMC contends the VA improperly bundled
             the anticipated purchase of these products with a potential 16-percent discount on
             any purchases made by VISN 7 under a separate Abbott immunoassay products
             BPA, thereby contravening the government's duty to promote full and open
             competition.

             We deny the protest.

             The VISN 7 blood glucose monitoring products BPA is part of a VA program to
             promote the standardization of pharmaceuticals and medic al/surgic al supply items
             in the hospital and clinic system operated by the Veterans Health Administration.
             As part of the program, the VA created the National Center for Laboratory Accuracy
             and Standardization. The Center conducted a study of monitoring systems and
             found that glucose monitoring products used for diabetes patients represented the
             single greatest over-the-counter supply cost for the VA in the year studied. The
             Center recommended that each VISN develop a multi-disciplinary committee
             consisting of primary care providers, diabetes specialists, nursing educators, and

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most